Hopes rise for a bright future for paediatric SPC extensions in the EU
This article was originally published in SRA
Executive Summary
It will be good news for the innovative pharmaceutical industry if the Court of Justice of the EU accepts the opinion of one of its advocates general that negative term supplementary protection certificates should be accepted in order to meet the objectives of the regulations governing SPCs and their extension. Mike Snodin reports.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.